JP2024540008A - 細菌感染症の処置のためのピペラジニルスルホニルアリール化合物 - Google Patents
細菌感染症の処置のためのピペラジニルスルホニルアリール化合物 Download PDFInfo
- Publication number
- JP2024540008A JP2024540008A JP2024525036A JP2024525036A JP2024540008A JP 2024540008 A JP2024540008 A JP 2024540008A JP 2024525036 A JP2024525036 A JP 2024525036A JP 2024525036 A JP2024525036 A JP 2024525036A JP 2024540008 A JP2024540008 A JP 2024540008A
- Authority
- JP
- Japan
- Prior art keywords
- piperazin
- pyrrolidin
- chloro
- pyridyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021126369 | 2021-10-26 | ||
| CNPCT/CN2021/126369 | 2021-10-26 | ||
| PCT/EP2022/079506 WO2023072794A1 (en) | 2021-10-26 | 2022-10-24 | Piperazinylsulfonylaryl compounds for treatment of bacterial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540008A true JP2024540008A (ja) | 2024-10-31 |
| JP2024540008A5 JP2024540008A5 (https=) | 2025-10-31 |
Family
ID=84361276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525036A Pending JP2024540008A (ja) | 2021-10-26 | 2022-10-24 | 細菌感染症の処置のためのピペラジニルスルホニルアリール化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250011300A1 (https=) |
| EP (1) | EP4436667B1 (https=) |
| JP (1) | JP2024540008A (https=) |
| CN (1) | CN118201916A (https=) |
| AR (1) | AR127435A1 (https=) |
| TW (1) | TW202325287A (https=) |
| WO (1) | WO2023072794A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024538778A (ja) * | 2021-10-12 | 2024-10-23 | エフ. ホフマン-ラ ロシュ アーゲー | 細菌感染症の処置のためのスルホニルピペラジニル化合物 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121127463A (zh) * | 2023-04-12 | 2025-12-12 | 豪夫迈·罗氏有限公司 | 用于治疗细菌感染的新颖化合物 |
| CN116942670B (zh) * | 2023-07-10 | 2024-09-27 | 重庆大学附属肿瘤医院 | ChemDiv L676-2179在制备鲍曼不动杆菌AdeABC外排泵抑制剂中的应用 |
| WO2025231273A1 (en) * | 2024-05-02 | 2025-11-06 | Arrepath, Inc. | Antibacterial compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003031443A1 (en) * | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
-
2022
- 2022-10-24 AR ARP220102877A patent/AR127435A1/es unknown
- 2022-10-24 US US18/704,018 patent/US20250011300A1/en active Pending
- 2022-10-24 JP JP2024525036A patent/JP2024540008A/ja active Pending
- 2022-10-24 WO PCT/EP2022/079506 patent/WO2023072794A1/en not_active Ceased
- 2022-10-24 CN CN202280070936.4A patent/CN118201916A/zh active Pending
- 2022-10-24 EP EP22809370.4A patent/EP4436667B1/en active Active
- 2022-10-25 TW TW111140471A patent/TW202325287A/zh unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024538778A (ja) * | 2021-10-12 | 2024-10-23 | エフ. ホフマン-ラ ロシュ アーゲー | 細菌感染症の処置のためのスルホニルピペラジニル化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250011300A1 (en) | 2025-01-09 |
| EP4436667B1 (en) | 2026-01-21 |
| AR127435A1 (es) | 2024-01-24 |
| TW202325287A (zh) | 2023-07-01 |
| EP4436667C0 (en) | 2026-01-21 |
| CN118201916A (zh) | 2024-06-14 |
| WO2023072794A1 (en) | 2023-05-04 |
| EP4436667A1 (en) | 2024-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4436667B1 (en) | Piperazinylsulfonylaryl compounds for treatment of bacterial infections | |
| JP2022523274A (ja) | Jak阻害剤化合物及びその使用 | |
| CA2953177C (en) | Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain | |
| KR102522832B1 (ko) | 호흡기 세포융합 바이러스 (rsv)의 복제에 대하여 저해 활성을 갖는 피페리딘 치환된 피라졸로[1,5―a]피리미딘 유도체 | |
| AU2017372377B2 (en) | Imidazo [1,5-a] pyrazine derivatives as PI3Kdelta inhibitors | |
| WO2022165530A1 (en) | Small molecule inhibitors of salt inducible kinases | |
| EP4486453A1 (en) | Benzamide compounds for treatment of bacterial infections | |
| AU2025203960A1 (en) | DNA Polymerase IIIC Inhibitors and Use Thereof | |
| US11339165B2 (en) | Pyrazolopyrimidines having activity against the respiratory syncytial virus (RSV) | |
| JP2022533429A (ja) | Rsvに対する活性を有する他のヘテロ芳香族化合物 | |
| US20220033396A1 (en) | Further heteroaromatic compounds having activity against rsv | |
| CA3183661A1 (en) | Receptor-interacting protein 1 inhibitors including piperazine heterocyclic amide ureas | |
| HK40109575A (zh) | 用於治疗细菌感染的哌嗪基磺酰基芳基化合物 | |
| CA3080623C (en) | Compound having erk kinase inhibitory activity and use thereof | |
| JP2024538778A (ja) | 細菌感染症の処置のためのスルホニルピペラジニル化合物 | |
| EP4695259A1 (en) | Tricyclic compounds for treatment of bacterial infections | |
| HK40128603A (zh) | 用於治疗细菌感染的三环化合物 | |
| JP2024521929A (ja) | 2,8-ジアザスピロ[4.5]デカン化合物 | |
| CN119816496A (zh) | 芳香乙炔类衍生物及其制备方法和用途 | |
| KR20230154382A (ko) | 신규한 pim 키나아제 억제 화합물 및 이의 용도 | |
| KR20220009349A (ko) | 아릴 또는 헤테로아릴 유도체, 및 이를 유효성분으로 포함하는 키나아제 관련 질환 예방 또는 치료용 약학적 조성물 | |
| HK1125632A (en) | Azaindoles useful as inhibitors of janus kinases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251023 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251023 |